Skip to content

Therapeutic effects of an advanced hippotherapy simulator in children with cerebral palsy

Study of the therapeutic effects of an advanced hippotherapy simulator in children with cerebral palsy: a randomised controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN03663478
Enrollment
37
Registered
2009-02-27
Start date
2008-10-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral palsy Nervous System Diseases Cerebral palsy

Interventions

The patients were classified into five levels according to the Gross Motor Function Classification System and subsequently randomly divided into two treatment groups: 1. Treatment Group with hippother

Sponsors

Regional Government of Aragon (Spain)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Children between 4 and 18 years old (either sex) with CP, who attend schools run by the Education Department of the Government of Aragon (Spain) and whose tutors have signed an informed consent form.

Exclusion criteria

Exclusion criteria: 1. Children who have undergone selective dorsal rhizotomy 2. Acute convulsions not controlled by medication 3. Allergy to electrode adhesives 4. Visual impairment not corrected with glasses 5. Those circumstances or associated illnesses that in the judgment of the researcher might interfere with the results or be detrimental to the children 6. Inability to attend intervention sessions or refusal to participate

Design outcomes

Primary

MeasureTime frame
Sitting balance: 1. Measurement of hip abduction range of motion, measured using an electronic inclinometer and traditional goniometer 2. Electromyographic activity in adductors, measured using surface electromyography (EMG) 3. Gross motor function, measured with the Gross Motor Function Measure (GMFM) and Sitting Assessment Scale (SAS)

Secondary

MeasureTime frame
Satisfaction of participants, measured using a 0 - 10 scale.

Countries

Spain

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 31, 2026